Musella Foundation awards 9 grants! Our largest grant was a payment of $250,000 towards a $1 Million pledge we made to open the compassionate use program for the experimental drug ONC-201 in the USA, and to track the patients so we learn from every patient's experiences. We are now saving for the next payment, due at the end of this year, as well as another $2 million to open the program in the rest of the world!
Webinar: Personalized Approaches to Treating Cancer Explained in Plain Language This is from our friends at Store My Tumor.Com They provide services to store and freeze your tumor sample from surgery, as well as help you get access to the services that can use this tissue such as specialized testing and even the creation of custom made vaccines!
Bayer’s regorafenib kicks off brain cancer platform trial This is the opening of the GBM AGILE trial, which will allow drugs to be tested much faster and easier for GBM. New drugs can be added and underperforming drugs dropped to home in on the best treatment or combination of treatments quickly!
I wish them luck!
